CULLINAN THERAPEUTICS, INC.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $78.6M | $75.1M | $88.3M | $103.3M | $72.8M | $76.7M | $83.0M | $102.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $342.0M | $361.4M | $386.8M | $342.2M | $275.9M | $317.8M | $414.7M | $592.0M |
| Property, Plant & Equipment | $263.0K | $342.0K | $421.0K | $489.0K | $569.0K | $607.0K | $683.0K | $760.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $363.8M | $403.0M | $448.4M | $484.1M | $520.3M | $579.7M | $621.8M | $653.3M |
| Liabilities | ||||||||
| Accounts Payable | $3.7M | $2.5M | $841.0K | $1.7M | $2.5M | $3.4M | $1.7M | $2.1M |
| Total Current Liabilities | $40.6M | $35.2M | $37.7M | $32.8M | $28.1M | $27.3M | $30.6M | $24.2M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $42.0M | $36.8M | $39.6M | $32.8M | $28.2M | $27.8M | $31.5M | $25.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-691.5M | $-637.8M | $-588.1M | $-537.4M | $-486.8M | $-416.7M | $-368.2M | $-320.6M |
| Total Stockholders' Equity | $321.8M | $366.2M | $408.7M | $451.4M | $492.1M | $551.8M | $590.3M | $627.9M |